In the lab and in the clinic, alisertib with TAK-228 excels against solid tumors
by CU Anschutz Medical CampusUniversity of Colorado Cancer Center investigator, Jennifer Diamond, MD, and colleagues report promising phase I results of alisertib with TAK-228 against solid tumor
Updated on: April 22,2024
14

In the lab and in the clinic, alisertib with TAK-228 excels against solid tumors
by CU Anschutz Medical CampusUniversity of Colorado Cancer Center investigator, Jennifer Diamond, MD, and colleagues report promising phase I results of alisertib with TAK-228 against solid tumor
Updated on:April 22,2024
14
